| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |